Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteins
US-11248219-B2 · Feb 15, 2022 · US
Chaddock John is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Chaddock John |
| Total patents | 12 |
| First publication | Jan 27, 2015 |
| Latest publication | Feb 15, 2022 |
Publications ranked by popularity score, then publication date.
US-11248219-B2 · Feb 15, 2022 · US
US-10619146-B2 · Apr 14, 2020 · US
US-2019309277-A1 · Oct 10, 2019 · US
US-2017327810-A1 · Nov 16, 2017 · US
US-2016369257-A1 · Dec 22, 2016 · US
US-9474807-B2 · Oct 25, 2016 · US
US-9243301-B2 · Jan 26, 2016 · US
US-9139635-B2 · Sep 22, 2015 · US
US-2015197739-A1 · Jul 16, 2015 · US
US-9072736-B2 · Jul 7, 2015 · US
Latest publications not already listed above.
US-9012195-B2 · Apr 21, 2015 · US
US-8940870-B2 · Jan 27, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Allergan Inc | 14 |
| Ipsen Bioinnovation Ltd | 8 |
| Syntaxin Ltd | 7 |
| Foster Keith | 3 |
| Chaddock John | 3 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P29/00 | 11 |
| A61K47/64 | 10 |
| A61K38/00 | 10 |
| A61K47/65 | 9 |
| C07K2319/01 | 9 |